Everything about bone marrow transplant (BMT) overseas — autologous vs allogeneic, HLA matching, conditioning regimens, infection risks, costs ($15K–$40K in India vs $300K+ in the US), and top accredited centres.
What Is a Bone Marrow Transplant?
A bone marrow transplant (BMT), also called a haematopoietic stem cell transplant (HSCT), replaces damaged or destroyed bone marrow with healthy stem cells. It's used to treat blood cancers (leukaemia, lymphoma, myeloma), aplastic anaemia, sickle cell disease, and some immune deficiency disorders.
The procedure involves high-dose chemotherapy (conditioning) to eradicate diseased marrow, followed by infusion of healthy stem cells that engraft and rebuild the blood-forming system over 2–4 weeks.
Autologous vs Allogeneic BMT
| Feature | Autologous (Self) | Allogeneic (Donor) |
|---|---|---|
| Stem cell source | Patient's own cells | Matched donor (sibling or unrelated) |
| Common uses | Myeloma, lymphoma | Leukaemia, aplastic anaemia, sickle cell |
| Graft-vs-Host risk | None | 20–50% (acute or chronic) |
| Hospital stay | 2–3 weeks | 4–6 weeks |
| Cost (India) | $15,000–$20,000 | $25,000–$40,000 |
| Cost (USA) | $150,000–$250,000 | $300,000–$500,000+ |
HLA Matching and Donor Search
For allogeneic transplants, the donor must be HLA-matched (Human Leucocyte Antigen). A full sibling has a 25% chance of being a perfect match. If no family match exists, registries like NMDP (US), Anthony Nolan (UK), DATRI (India), and DKMS search their global database of 40 million+ donors.
Haploidentical transplants (half-matched family donors) have improved significantly with post-transplant cyclophosphamide protocols, expanding options for patients without a full match.
The Transplant Process Step by Step
- Pre-transplant evaluation (1–2 weeks): cardiac, pulmonary, dental, and infection screening
- Central line placement: a Hickman catheter is inserted for IV access
- Conditioning (5–10 days): high-dose chemo ± radiation to destroy existing marrow
- Transplant day (Day 0): stem cells are infused via catheter — similar to a blood transfusion
- Engraftment (Day +10 to +28): new cells begin producing blood; critical infection risk period
- Recovery monitoring (Day +30 to +100): outpatient visits, GVHD monitoring, medication tapering
Risks and Complications
- Graft-vs-Host Disease (GVHD) — the transplanted immune cells attack the recipient's organs (skin, liver, gut). Acute GVHD occurs in 20–50% of allogeneic transplants
- Infection — viral (CMV, EBV), bacterial, and fungal infections during the neutropenic period
- Engraftment failure — occurs in 1–5% of cases; may need a second transplant
- Organ toxicity — conditioning drugs can affect the liver (veno-occlusive disease), lungs, and kidneys
- Secondary cancers — long-term risk of MDS or leukaemia from conditioning drugs
Cost Comparison by Country
| Country | Autologous BMT | Allogeneic BMT | Savings vs US |
|---|---|---|---|
| United States | $150K–$250K | $300K–$500K+ | — |
| India | $15K–$20K | $25K–$40K | 85–92% |
| Thailand | $40K–$60K | $60K–$100K | 70–80% |
| Turkey | $30K–$50K | $50K–$80K | 75–83% |
Top Accredited BMT Centres
When choosing a BMT centre abroad, look for:
- FACT accreditation (Foundation for Accreditation of Cellular Therapy) — the gold standard for transplant programmes
- Annual transplant volume — centres performing 100+ BMTs per year have better outcomes
- HEPA-filtered isolation rooms — essential for infection prevention
- 24/7 blood bank — platelet transfusions may be needed daily during engraftment
Related Treatment Guides
Looking for the best hospital?
Let our experts help you find the right hospital for your treatment. Get a free consultation today.
